What does CUSIP 803607100 represent in this 13F holders report?

CUSIP 803607100 is the security identifier for SRPT - Sarepta Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held SRPT - Sarepta Therapeutics, Inc. - Common Stock in Q2 2020?

397 institutional investors reported SRPT - Sarepta Therapeutics, Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Sarepta Therapeutics, Inc. - Common Stock (SRPT)

CUSIP: 803607100

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 104,849,534
Total 13F shares: 73,863,151
Share change: +251,661
Total reported value: $11,844,121,308
Put/Call ratio: 87%
Price per share: $160.34
Number of holders: 397
Value change: +$150,679,056
Number of buys: 206
Number of sells: 166

Quarterly Holders Quick Answers

What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 803607100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.1%	7,414,794	$725,315,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	6.2%	6,544,789	$640,211,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	4.7%	4,887,444	$478,088,000	—	31 Mar 2020	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	4.2%	4,402,931	$430,695,000	—	31 Mar 2020	13F
Capital Research Global Investors	13F	Company	3.7%	3,874,958	$379,048,000	—	31 Mar 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.4%	3,523,983	$344,715,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	2%	2,054,794	$201,000,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.9%	2,025,000	$198,086,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.6%	1,686,799	$165,003,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.5%	1,606,770	$157,171,000	—	31 Mar 2020	13F
Avoro Capital Advisors LLC	13F	Company	1.5%	1,585,000	$155,045,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	1.5%	1,554,669	$152,078,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.3%	1,325,872	$129,697,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	1.1%	1,144,463	$111,951,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	1.1%	1,136,389	$111,162,000	—	31 Mar 2020	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.1%	1,132,303	$110,762,000	—	31 Mar 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.95%	996,000	$97,429,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.9%	945,412	$92,481,000	—	31 Mar 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.89%	928,282	$90,805,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.86%	902,449	$88,278,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.83%	866,686	$84,780,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	850,806	$83,158,000	—	31 Mar 2020	13F
Consonance Capital Management LP	13F	Company	0.79%	823,165	$80,522,000	—	31 Mar 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.74%	775,920	$75,900,000	—	31 Mar 2020	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.72%	753,836	$73,740,000	—	31 Mar 2020	13F
Camber Capital Management LP	13F	Company	0.69%	725,000	$70,920,000	—	31 Mar 2020	13F
Casdin Capital, LLC	13F	Company	0.64%	670,000	$65,539,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.55%	576,123	$56,356,000	—	31 Mar 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.51%	530,378	$51,882,000	—	31 Mar 2020	13F
RTW INVESTMENTS, LP	13F	Company	0.5%	529,261	$51,772,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.48%	504,294	$49,330,000	—	31 Mar 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.48%	503,731	$49,275,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.46%	487,057	$47,645,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.45%	467,228	$45,704,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.45%	467,212	$45,703,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.44%	460,827	$45,078,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.43%	455,859	$44,592,126	—	31 Mar 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.42%	440,410	$43,080,000	—	31 Mar 2020	13F
Erste Asset Management GmbH	13F	Company	0.41%	426,260	$41,780,193	—	31 Mar 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.39%	410,484	$40,154,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.38%	394,192	$38,561,000	—	31 Mar 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.33%	350,000	$34,237,000	—	31 Mar 2020	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.33%	346,086	$33,854,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	0.33%	345,500	$33,797,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.32%	340,506	$33,309,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.32%	338,001	$33,064,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	336,242	$32,892,000	—	31 Mar 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.32%	339,743	$31,596,099	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.28%	289,373	$28,306,000	—	31 Mar 2020	13F
Holocene Advisors, LP	13F	Company	0.25%	258,897	$25,325,000	—	31 Mar 2020	13F

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q2 2020

As of 30 Jun 2020, Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by 397 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,863,151 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Capital Research Global Investors, SANDS CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 397 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

346

Q2 2020 holders

397

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.